In animal study, implant churns out CAR-T cells to combat cancer
Researchers have developed an implantable biotechnology that produces and releases CAR-T cells for attacking cancerous tumors. In a proof-of-concept study involving lymphoma in mice, the researchers found that treatment with the implants was faster and more effective than conventional CAR-T cell cancer treatment.
Materials provided by North Carolina State University. Original written by Matt Shipman. Note: Content may be edited for style and length.
Source link aaaaa